Cognex Corporation $CGNX Stock Holdings Boosted by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership grew its position in shares of Cognex Corporation (NASDAQ:CGNX) by 115.6% during the 1st quarter, Holdings Channel reports. The firm owned 2,033,091 shares of the scientific and technical instruments company’s stock after purchasing an additional 1,090,092 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Cognex were worth $99,601,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Geneos Wealth Management Inc. lifted its holdings in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 736 shares during the period. CIBC Private Wealth Group LLC grew its holdings in Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Cassaday & Co Wealth Management LLC acquired a new position in Cognex during the first quarter worth about $36,000. Caitong International Asset Management Co. Ltd acquired a new position in Cognex during the fourth quarter worth about $39,000. Finally, Larson Financial Group LLC raised its position in Cognex by 202.7% in the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after acquiring an additional 740 shares in the last quarter. Institutional investors own 88.12% of the company’s stock.

Insiders Place Their Bets

In other news, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the sale, the insider owned 11,263 shares of the company’s stock, valued at $755,184.15. This trade represents a 85.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Laura Ann Macdonald sold 98,122 shares of Cognex stock in a transaction on Monday, May 11th. The shares were sold at an average price of $66.80, for a total value of $6,554,549.60. Following the transaction, the vice president owned 5,258 shares in the company, valued at $351,234.40. This represents a 94.91% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 224,847 shares of company stock worth $14,975,098. Corporate insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on CGNX. Truist Financial upped their price target on shares of Cognex from $61.00 to $71.00 and gave the company a “hold” rating in a report on Thursday, July 2nd. JPMorgan Chase & Co. upgraded shares of Cognex from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $65.00 to $75.00 in a report on Tuesday, May 26th. Barclays reiterated an “overweight” rating and issued a $75.00 target price (up from $64.00) on shares of Cognex in a report on Monday, May 11th. Zacks Research upgraded shares of Cognex from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 16th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Cognex currently has an average rating of “Moderate Buy” and a consensus price target of $72.31.

Cognex Trading Down 2.2%

Shares of CGNX opened at $62.05 on Friday. The business’s 50-day moving average price is $64.97 and its 200 day moving average price is $55.34. The stock has a market capitalization of $10.33 billion, a P/E ratio of 73.87 and a beta of 1.49. Cognex Corporation has a 1-year low of $33.45 and a 1-year high of $72.88.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The business’s quarterly revenue was up 24.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, research analysts predict that Cognex Corporation will post 1.48 earnings per share for the current year.

Cognex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 4th. Investors of record on Thursday, May 21st were paid a $0.085 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s dividend payout ratio (DPR) is currently 40.48%.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.